Advanced search
Publication Cover
Clinical Ophthalmology Volume 13, 2019 - Issue
Submit an article Journal homepage
91
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity

Shumpei Obata1 Department of Ophthalmology, Shiga University of Medical Science, Otsu, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6120-2392
ORCID Icon,
Tomoaki Higashiyama1 Department of Ophthalmology, Shiga University of Medical Science, Otsu, Japan
,
Taku Imamura1 Department of Ophthalmology, Shiga University of Medical Science, Otsu, Japan
,
Masashi Kakinoki1 Department of Ophthalmology, Shiga University of Medical Science, Otsu, Japan
,
Takahide Yanagi2 Department of Pediatrics, Shiga University of Medical Science, Otsu, JapanORCID Iconhttps://orcid.org/0000-0002-4524-3167
ORCID Icon,
Yoshihiro Maruo2 Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan
&
Masahito Ohji1 Department of Ophthalmology, Shiga University of Medical Science, Otsu, Japan
 show all
Pages 2445-2449 | Published online: 10 Dec 2019

References

  • Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev. 2008;84(2):77–82. doi:10.1016/j.earlhumdev.2007.11.009
  • Early Treatment For Retinopathy Of Prematurity Cooperative G. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121(12):1684–1694. doi:10.1001/archopht.121.12.1684
  • Kychenthal A, Dorta P, Katz X. Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes. Retina. 2006;26(7 Suppl):S11–5. doi:10.1097/01.iae.0000244285.79004.e6
  • Soh Y, Fujino T, Hatsukawa Y. Progression and timing of treatment of zone I retinopathy of prematurity. Am J Ophthalmol. 2008;146(3):369–374. doi:10.1016/j.ajo.2008.05.010
  • Drenser KA, Trese MT, Capone A Jr. Aggressive posterior retinopathy of prematurity. Retina. 2010;30(4 Suppl):S37–S40. doi:10.1097/IAE.0b013e3181cb6151
  • Mintz-Hittner HA, Kennedy KA, Chuang AZ, Group B-RC. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364(7):603–615. doi:10.1056/NEJMoa1007374
  • Benz MS, Albini TA, Holz ER, et al. Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide. Ophthalmology. 2006;113(7):1174–1178. doi:10.1016/j.ophtha.2005.10.061
  • Falkenstein IA, Cheng L, Freeman WR. Changes of intraocular pressure after intravitreal injection of bevacizumab (avastin). Retina. 2007;27(8):1044–1047. doi:10.1097/IAE.0b013e3180592ba6
  • Hollands H, Wong J, Bruen R, Campbell RJ, Sharma S, Gale J. Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol. 2007;42(6):807–811. doi:10.3129/i07-172
  • Kim JE, Mantravadi AV, Hur EY, Covert DJ. Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents. Am J Ophthalmol. 2008;146(6):930–4 e1. doi:10.1016/j.ajo.2008.07.007
  • Lee JW, Park H, Choi JH, et al. Short-term changes of intraocular pressure and ocular perfusion pressure after intravitreal injection of bevacizumab or ranibizumab. BMC Ophthalmol. 2016;16:69. doi:10.1186/s12886-016-0255-8
  • Kato A, Okamoto Y, Okamoto F, Saito M, Miyazono Y, Oshika T. Short-term intraocular pressure changes after intravitreal injection of bevacizumab for retinopathy of prematurity. Jpn J Ophthalmol. 2019;63(3):262–268. doi:10.1007/s10384-019-00661-y
  • Tucker SM, Enzenauer RW, Levin AV, Morin JD, Hellmann J. Corneal diameter, axial length, and intraocular pressure in premature infants. Ophthalmology. 1992;99(8):1296–1300. doi:10.1016/S0161-6420(92)31812-3
  • Cacciamani A, Oddone F, Parravano M, Scarinci F, Di Nicola M, Lofoco G. Intravitreal injection of bevacizumab: changes in intraocular pressure related to ocular axial length. Jpn J Ophthalmol. 2013;57(1):63–67. doi:10.1007/s10384-012-0194-8
  • Muint Y, Singh AK, Peacock JE, Padfield A. Changes in intra-ocular pressure during general anaesthesia: a comparison of spontaneous breathing through a laryngeal mask with positive pressure ventilation through a tracheal tube. Anaesthesia. 1995;50(2):126–129. doi:10.1111/j.1365-2044.1995.tb15094.x
  • Sato T, Wada K, Arahori H, et al. Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity. Am J Ophthalmol. 2012;153(2):327–333 e1. doi:10.1016/j.ajo.2011.07.005
  • Hong YR, Kim YH, Kim SY, Nam GY, Cheon HJ, Lee SJ. Plasma concentrations of vascular endothelial growth factor in retinopathy of prematurity after intravitreal bevacizumab injection. Retina. 2015;35(9):1772–1777. doi:10.1097/IAE.0000000000000535
  • Zhou Y, Jiang Y, Bai Y, Wen J, Chen L. Vascular endothelial growth factor plasma levels before and after treatment of retinopathy of prematurity with ranibizumab. Graefes Arch Clin Exp Ophthalmol. 2016;254(1):31–36. doi:10.1007/s00417-015-2996-0
  • Wallace DK, Kraker RT, Freedman SF, et al. Assessment of lower doses of intravitreous bevacizumab for retinopathy of prematurity: a phase 1 dosing study. JAMA Ophthalmol. 2017;135(6):654–656. doi:10.1001/jamaophthalmol.2017.1055

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.